These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29845475)

  • 1. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
    Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.
    Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J
    Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Tiirikainen M; Yu H
    FEBS Open Bio; 2019 Jul; 9(7):1270-1280. PubMed ID: 31102318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer.
    Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB
    Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
    Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
    Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Qiao W; Liu H; Guo W; Li P; Deng M
    Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
    Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
    JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
    Yang Y; Qian J; Xiang Y; Chen Y; Qu J
    Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of increased MALAT1 expression with pathological features and prognosis in cancer patients: a meta-analysis.
    Shi XS; Li J; Yang RH; Zhao GR; Zhou HP; Zeng WX; Zhou M
    Genet Mol Res; 2015 Dec; 14(4):18808-19. PubMed ID: 26782531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast Cancer.
    Yu J; Jin T; Zhang T
    Med Sci Monit; 2020 Jul; 26():e922672. PubMed ID: 32623440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis.
    Sun Z; Liu J; Liu J
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):72-78. PubMed ID: 32538750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
    Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
    Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
    Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
    BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ILK1 in breast cancer associates with poor prognosis.
    Yang HJ; Zheng YB; Ji T; Ding XF; Zhu C; Yu XF; Ling ZQ
    Tumour Biol; 2013 Dec; 34(6):3933-8. PubMed ID: 23832543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of long non-coding RNA
    Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
    Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients.
    Huang C; Yu Z; Yang H; Lin Y
    Biomed Pharmacother; 2016 Oct; 83():8-13. PubMed ID: 27470544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of triple negative phenotype on breast cancer prognosis.
    Kaplan HG; Malmgren JA
    Breast J; 2008; 14(5):456-63. PubMed ID: 18657139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.